Brian Baranick, EVP, GM, Precision Oncology at EXACT SCIENCES CORP (EXAS), sold 110 shares at $60.15 ($7K) on 2024-05-01, disclosed to the SEC on 2024-05-02.
Scheduled sale ($7k) by EVP, GM, Precision Oncology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EXAS | SELL | 2024-09-19 | $65K | — | Filing → |
| EXAS | SELL | 2024-04-03 | $147K | — | Filing → |
| EXAS | SELL | 2024-03-04 | $276K | — | Filing → |